Connect with us

cannabis policy

Republican Congressman Plans to Reintroduce Bill to Reschedule Cannabis 

Published

on

Republican Congressman Plans to Reintroduce Bill to Reschedule Cannabis 

Rep. Greg Steube (R-FL) has shown plans to restore a 1-in-3 marijuana-3 mass-to move cannabis from the federal act of controlled substances (CSA) in Program III. In a post on X, Steube called the proposal “a change of common sense that will finally allow true scientific research in its medicinal value and ensure that our drug laws reflect reality.”

“It makes sense that federal law treats marijuana just like heroin and LSD. It is even more ridiculous that cocaine is technically classified as less restrictive than marijuana.” – Steube in a post on x

Steube first proposed legislation in 2023. According to Bill’s compilation, it would direct the drug implementation administration (DEA) to make the transfer. The move never made it from neither the Energy and Trade Committee nor the Judicial Committee.

Steube’s announcement comes days after reporting that President Donald Trump (R) told attendees about a private funding at his private club in Bedminster, New Jersey, that he is considering reconstruction of cannabis under CSA. During a press conference on Monday, Trump said the administration is “watching reclassification” and “would determine over the next few weeks”.

“Some people like it, some people hate it,” Trump said during the oppressor. “Some people hate the whole concept of marijuana because it does bad for children, it does bad for people who are older than children.”

A plan to renew cannabis under the CSA was first set up by President Joe Biden (d) last May, but stalled in January when DEA John Mulrooney Administrative Judge, who was chairing hearing, decided to allow the future Trump administration to decide whether to reunite the process. Mulrooney recently retired which leaves the issue only with the new Dea Terrance Cole administrator.

Steube’s bill has not yet been returned.

TG joined Ganjapreur in 2014 as a news writer and began waiting for Podcast Ganjapreurur in 2016. He is located at the Upsstate New York, where he also teaches media studies at a local university.

Continue Reading

adult use

Massachusetts Cannabis Operators Sue to Block Adult-Use Repeal Effort

Published

on

By

Massachusetts Cannabis Operators Sue to Block Adult-Use Repeal Effort

Four Massachusetts cannabis operators have filed a legal challenge against the ballot initiative that seeks to repeal the state’s adult-use market this November. Bloomberg Law reports.

of suitfiled Wednesday in the Supreme Judicial Court, claims the ballot measure violates the state constitution by combining too many issues into a single ballot question and because of its “failure to present a unified statement of public policy to voters.”

The ballot measure, titled “An Act to Restore Sensible Marijuana Policy,” was approved for this year’s ballot in January. despite the allegations that the reform campaign used deceptive signature-gathering practices, including bait-and-switch tactics and signers lying about the purpose of the petition.

The suit names Attorney General Andrea Campbell and Secretary of State William Galvin as defendants for their roles in allowing the petition to move forward. The complaint asks “that this Court vacate the Attorney General’s certification of the Petition and order the Secretary of the Commonwealth to place the Petition on the ballot for the 2026 general election.”

If approved by voters, the ballot initiative would repeal adult-use cannabis sales and the state’s home grow provisions. Instead, the initiative contains language to decriminalize possession of up to two ounces of cannabis.

or survey found last month that only 20% of Massachusetts residents said they would support the repeal of the state-owned adult-use industry.

Based in Portland, Oregon, Graham is the editor-in-chief of Ganjapreneur. He has been writing about the legalization landscape since 2012 and has contributed to Ganjapreneur since our official launch in…

Continue Reading

cannabis policy

Anti-Cannabis Coalition Sues Trump Admin Over Medicare Hemp Coverage Plan

Published

on

By

Anti-Cannabis Coalition Sues Trump Admin Over Medicare Hemp Coverage Plan

A coalition of health advocacy organizations and anti-cannabis groups sued the Trump administration on Monday over its plan to allow Medicare coverage for hemp-derived CBD and THC products. Plaintiffs include Smart Approaches to Marijuana, Cannabis Industry Victims Educating Judges, North Carolinians Against Legalization of Marijuana, Cannabis Impact Prevention Coalition, LLC, Cannabis Industry Victims Seeking Justice, County Drug Foundation of America, Save Drugs Courses International Anti-Drug Alliance, Illinois Family Institute and North Carolina resident and SAM donor David Evans.

The lawsuit was filed after the Centers for Medicare & Medicaid Services (CMS) will begin covering CBD and THC products as an incentive to engage beneficiaries of substance access (BEI). The document names CMS Administrator Mehmet Oz and US Department of Health and Human Services (HHS) Secretary Robert F. Kennedy, Jr. as a defendant.

Under the proposed BEI, patients enrolled in certain federal health insurance programs could cover up to $500 worth of hemp-derived products each year. The lawsuit alleges that the plan violates administrative rules because the CBD and THC products covered by the program have not received Food and Drug Administration approval and because CMS did not publish a notice of proposed rulemaking, which prevented public comment.

The complaint further alleges that the program would violate the Social Security Act, which “does not permit CMS to sanction the possession and use of illegal and dangerous Schedule I substances by Medicare patients without express congressional authorization.”

“CMS’s action represents an unprecedented and unlawful assertion of binding decision-making authority that will profoundly affect the health of older Americans. “CMS took this action without the hurdles imposed by the administrative process, without any reasoned explanation, in violation of the agency’s final determination pursuant to the APA, and without statutory authority.” – Smart approaches to marijuana, etc. al v. HHS, US CMS

The filing alleges that Evans would be personally harmed by CMS’ changes because he is a Medicare recipient who was not allowed to submit public comment on the BEI and whose “health care relationship” with CMS is changed by the plan.

The lawsuit alleges that there is a “research gap” for medical cannabis and hemp products and alleges that “commercially available CBD products are contaminated and mislabeled.”

The suit seeks a temporary restraining order, a preliminary injunction, a stay of the agency’s action pending a judicial review, and asks the court to vacate the EIB, declare it illegal and permanently enjoin the policy.

Continue Reading

cannabis policy

Mississippi Gov. Vetoes Medical Cannabis Reform Bills 

Published

on

By

Mississippi Gov. Vetoes Medical Cannabis Reform Bills 

Mississippi Gov. Tate Reeves (R) vetoed it last week two laws that provided state law updates on medical cannabis. Together, the bills would have allowed ‘right to try’ provisions for patients and loosened rules on doctor visits. The reforms would also have eliminated THC caps on some medical cannabis products.

In his veto of the bill to loosen regulations and end some of the THC limits, Reeves said the legislation “seeks to erode three important safeguards” in state law “intended to minimize the potential diversion” of medical cannabis “for recreational purposes.”

“Requiring a mandatory six-month follow-up visit to ensure the patient is receiving a therapeutic benefit from the use of medical marijuana; requiring caregivers to pass an annual criminal background check; and limiting THC potency to 60% for oils and concentrates are reasonable and necessary checks and balances in the medical marijuana program and do not create barriers.” – Reeves in his the veto message

The vetoed bill was referred back to the House Committee on Business and Commerce

In his veto of the ‘right to try’ bill, Reeves said the bill would “extend the ‘right to try medical cannabis’ to every person on the planet”, which he opposes.

In the veto message, Reeves mentioned the concern of Dr. Daniel Edney, state health officer, who said the proposal “shifts the intent of the bill from giving Mississippians the ability to work with their treating physicians in dire situations when all other options have failed.”

“This policy position of the (Mississippi State Department of Health) was clearly communicated to leadership and the committee that we can only support this narrowly drafted and strict language,” the veto message said, citing Edney, “and will not support anything to make the program more outdoor fun. Unfortunately, the amended language distorts the intent of the bill’s original text.”

The vetoed bill returned to the House Public Health and Human Services Committee.

Continue Reading
Advertisement

Trending

Copyright © 2021 The Art of MaryJane Media